journal article·2018-08-29

Molecular Dynamics Simulations on Nucleic Acid Binding Polymers Designed To Arrest Thrombosis

Deniz Meneksedag-Erol, Jayachandran N. Kizhakkedathu, Tian Tang, Hasan Uludağ

ACS Applied Materials & Interfaces· Volume 10· Issue 34
Publisher page

Abstract

Cancer-associated thrombosis is managed by the administration of anticoagulants and antithrombotic agents that have a high risk of inducing hemorrhagic complications. To develop safer strategies for antithrombotic therapy, in vivo activators of the intrinsic pathway, namely, cell-free nucleic acids (DNA and RNA) have been targeted with cationic, polyamine-based polymers. The cytotoxicity of the highly cationic polymers is a major drawback for their practical use, and biocompatible alternatives are in high demand. In this study, we carried out all-atom molecular dynamics simulations to systematically examine the DNA binding of polyamine-poly(ethylene glycol) (PEG) diblock polymers designed from biocompatible building blocks to inhibit the procoagulant activity of DNA. The differences in cationic charge, PEG chain length, and initial conformations of the polymers resulted in marked differences in their binding to DNA. We found that having an exposed cationic polyamine group is essential to polymer-DNA binding and a certain level of electrostatic interactions is necessary to maintain the bound state. Intrachain associations between the polyamine groups and PEG chains in some cases have led to a collapsed state of the polymer that precludes binding to DNA. This self-association is mainly due to a strong hydrogen bond between polymer polyamine and PEG groups and partly due to a partially charged semibranched polyamine group architecture. As polymer "masking" of DNA is thought to arrest DNA's prothrombotic activity, our findings highlight the desired structural features of the polymers for stronger DNA binding and provide insights into the design of novel antithrombotic agents.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Monoclonal and Polyclonal Antibodies Research · Click Chemistry and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biomedical Engineering, University of Alberta, Edmonton, Alberta T6G 2V2, Canada

Centre for Blood Research, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada

Department of Chemistry, University of British Columbia, Vancouver, British Columbia V6T 1Z1, Canada

Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2H7, Canada

Funding

Canadian Institutes of Health Research · Natural Sciences and Engineering Research Council of Canada · Michael Smith Foundation for Health Research

References (45)

Show source-provided references
1. Rickles F. R. · Blood · 1983 · 62 · 1410.1182/blood.V62.1.14.14 ↗
2. 10.1055/s-2007-99582910.1055/s-2007-995829 ↗
3. 10.1182/blood-2002-01-010810.1182/blood-2002-01-0108 ↗
4. 10.1111/jth.1300910.1111/jth.13009 ↗
5. 10.1160/TH13-10-081210.1160/TH13-10-0812 ↗
6. 10.1182/blood-2012-07-29209410.1182/blood-2012-07-292094 ↗
7. 10.1073/pnas.060864710410.1073/pnas.0608647104 ↗
8. Leon S. A. · Cancer Res. · 1977 · 37 · 646
9. Kopreski M. S. · Clin. Cancer Res. · 1999 · 5 · 1961
10. Ng E. K. O. · Clin. Chem. · 2002 · 48 · 121210.1093/clinchem/48.8.1212 ↗
11. 10.1002/1097-0142(19830601)51:11<2116::AID-CNCR2820511127>3.0.CO;2-S10.1002/1097-0142(19830601)51:11<2116::AID-CNCR2820511127>3.0.CO;2-S ↗
12. 10.1182/blood-2013-04-46016210.1182/blood-2013-04-460162 ↗
13. 10.1073/pnas.120492810910.1073/pnas.1204928109 ↗
14. 10.1073/pnas.050719510310.1073/pnas.0507195103 ↗
15. 10.1016/j.cell.2009.11.00110.1016/j.cell.2009.11.001 ↗
16. 10.1182/blood-2012-07-44493510.1182/blood-2012-07-444935 ↗
17. 10.1182/blood-2015-01-62281110.1182/blood-2015-01-622811 ↗
18. 10.1021/nn303472r10.1021/nn303472r ↗
19. 10.1016/S0142-9612(02)00445-310.1016/S0142-9612(02)00445-3 ↗
20. 10.1021/mp200463e10.1021/mp200463e ↗
21. 10.1021/mp200605410.1021/mp2006054 ↗
22. 10.1182/blood-2014-05-57793210.1182/blood-2014-05-577932 ↗
23. 10.1182/blood-2016-10-74791510.1182/blood-2016-10-747915 ↗
24. 10.1126/scitranslmed.300942710.1126/scitranslmed.3009427 ↗
25. 10.1021/acs.biomac.7b0099410.1021/acs.biomac.7b00994 ↗
26. 10.1016/j.bpj.2011.04.04510.1016/j.bpj.2011.04.045 ↗
27. 10.1021/ct200723y10.1021/ct200723y ↗
28. 10.1002/jcc.2136710.1002/jcc.21367 ↗
29. 10.1021/jp973084f10.1021/jp973084f ↗
30. 10.1002/jcc.2028910.1002/jcc.20289 ↗
31. 10.1063/1.46439710.1063/1.464397 ↗
32. 10.1016/0021-9991(77)90098-510.1016/0021-9991(77)90098-5 ↗
33. 10.1016/0263-7855(96)00018-510.1016/0263-7855(96)00018-5 ↗
34. 10.1021/acs.biomac.8b0032710.1021/acs.biomac.8b00327 ↗
35. 10.1006/jmbi.2001.464210.1006/jmbi.2001.4642 ↗
36. 10.1016/S0006-3495(02)75628-210.1016/S0006-3495(02)75628-2 ↗
37. 10.1093/nar/gkg80210.1093/nar/gkg802 ↗
38. 10.1007/s00249-004-0410-710.1007/s00249-004-0410-7 ↗
39. 10.1002/bip.1058310.1002/bip.10583 ↗
40. 10.1021/jp211716v10.1021/jp211716v ↗
41. 10.1016/j.bpj.2009.03.06910.1016/j.bpj.2009.03.069 ↗
42. Jeffrey G. A. · 1994
43. 10.1016/0079-6107(84)90007-510.1016/0079-6107(84)90007-5 ↗
44. 10.1002/jrs.125020040710.1002/jrs.1250200407 ↗
45. 10.1007/BF0012621710.1007/BF00126217 ↗